Buchumschlag

Down-regulation of ABCC11 protein (MRP8) in human breast cancer

Aim of this article is to investigate the expression of ABCC11 (MRP8) protein in normal breast tissue, and examine the difference in ABCC11 mRNA and protein expression between normal breast and breast cancer tissues taking into account ABCC11 genotype (a functional SNP, rs17822931) and estrogen rece...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental Oncology
Datum:	2011
Hauptverfasser:	Sosonkina, N., Nakashima, M., Ohta, T., Niikawa, N., Starenki, D.
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2011
Schlagworte:	Original contributions
Online Zugang:	https://nasplib.isofts.kiev.ua/handle/123456789/32317
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	Down-regulation of ABCC11 protein (MRP8) in human breast cancer / N. Sosonkina, M. Nakashima, T. Ohta, N. Niikawa, D. Starenki // Experimental Oncology. — 2011. — Т. 33, № 1. — С. 42–46. — Біліогр.: 22 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

Genetic polymorphisms of the renin-angiotensin system in breast cancer patients
von: Fishchuk, L.E., et al.
Veröffentlicht: (2013)

Chromosomal Radiosensitivity in Ukrainian breast cancer patients and healthy Individuals
von: Ryabchenko, N.M., et al.
Veröffentlicht: (2012)

Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
von: Ryspayeva, D.E., et al.
Veröffentlicht: (2017)

Aspisol inhibits tumor growth and induces apoptosis in breast cancer
von: Zhu, X.G., et al.
Veröffentlicht: (2008)

Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer
von: Yu, Z., et al.
Veröffentlicht: (2007)

Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
von: Zavyalova, M., et al.
Veröffentlicht: (2016)

Breast cancer immunohistochemical features in young women with BRCA1/2 mutations
von: Zakhartseva, L.M., et al.
Veröffentlicht: (2009)

Breast cancer immunohistochemical features in young women with BRCA1/2 mutations
von: Zakhartseva, L.M., et al.
Veröffentlicht: (2009)

The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
von: Todor, I.N., et al.
Veröffentlicht: (2012)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
von: Chekhun, S.V., et al.
Veröffentlicht: (2014)

Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
von: Rusetskaya, N.V., et al.
Veröffentlicht: (2011)

OX40L gene polymorphism and breast cancer in Iranian population
von: Vakil Monfared, R., et al.
Veröffentlicht: (2018)

The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer
von: Ürün, Y., et al.
Veröffentlicht: (2015)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
von: Chekhun, V.F., et al.
Veröffentlicht: (2015)

Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
von: Lukyanova, N.Yu.
Veröffentlicht: (2010)

Cytogenetic effects of neutron therapy in patients with parotid gland tumors and relapse of breast cancer
von: Melnikov, A.A., et al.
Veröffentlicht: (2012)

Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells
von: Bezdenezhnykh, N., et al.
Veröffentlicht: (2014)

Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
von: Naleskina, L.A., et al.
Veröffentlicht: (2016)

Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
von: Kryzhanivska, A.E., et al.
Veröffentlicht: (2018)

Increased homocysteine plasma levels in breast cancer patients of a Mexican population
von: Varela Almanza, K.M., et al.
Veröffentlicht: (2018)

Comparative study of dye-loaded liposome accumulation in sensitive and resistant human breast cancer cells
von: Yefimova, S.L., et al.
Veröffentlicht: (2012)

Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2016)

СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
von: Chekhun, S.V., et al.
Veröffentlicht: (2015)

Genome-wide association study of loss of heterozygosity and metastasis-free survival in breast cancer patients
von: Deryusheva, I.V., et al.
Veröffentlicht: (2017)

Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
von: Zekri, J., et al.
Veröffentlicht: (2015)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: Chekhun, S., et al.
Veröffentlicht: (2013)

Establishment and characterization of new breast and ovarian cancer cell lines as a model for studying cellular plasticity in vitro
von: Bezdieniezhnykh, N., et al.
Veröffentlicht: (2016)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
von: Yalovenko, T.M., et al.
Veröffentlicht: (2016)

Expression of E-cadherin in drug resistant human breast cancer cells and their sensitivity to lymphokine-activated lymphocytes action
von: Berezhnaya, N.M., et al.
Veröffentlicht: (2009)

Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2016)

Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

High body-mass index is not associated with worse clinicopathological characteristics in predominantly obese breast cancer patients
von: Kemal, Y., et al.
Veröffentlicht: (2015)

Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS
von: Zheng, G.X., et al.
Veröffentlicht: (2006)

Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects
von: Berstein, L.M., et al.
Veröffentlicht: (2006)

Association of polymorphic G1934A variant (allele *4) of CYP2D6 gene with increased risk of breast cancer development in Ukrainian women
von: Levkovich, N.N., et al.
Veröffentlicht: (2011)

Down regulation of u-PA by a nutrient mixture in hemangioma (EOMA) cells by inducing caspase-dependent apoptosis
von: Roomi, M.W., et al.
Veröffentlicht: (2018)

Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
von: Zalutski, I.V., et al.
Veröffentlicht: (2017)

Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
von: Timovska, Yu.O., et al.
Veröffentlicht: (2009)